Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases

NCT00041574 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.

NCT NCT00041574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00041574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Hospital-Based Home Program for the Use of Inhaled Nitric Oxide in the Chronic Management of Severe Cardiopulmonary Diseases
Lead sponsor
Mallinckrodt
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2002
Completion date
December 31, 2005
Enrollment
7 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac transplant, lung disease, lung transplant, pulmonary hypertension, sickle cell disease